Abstract
The role of individual fatty acids in blood pressure regulation is unclear, although it is known that the modifications in the levels of fatty acids in the diet are able to change the entire profile of fatty acids as well as cholesterol levels in cellular membranes. These chemical changes are accompanied by changes in the physiological state of the cellular membranes and have suggested an influence on cellular metabolism and of course, on the regulatory processes. Local and circulating renin-angiotensin-systems (RAS) are examples of systems that may be involved in the pathogenesis of hypertension. Angiotensin II (AngII) has been considered as the main effector peptide of the RAS, but other peptides derived from the metabolism of AngII, as angiotensin III (AngIII) and angiotensin IV (AngIV) have shown to play significant roles. This review will briefly summarize what is known about the effects of fatty acids, cholesterol and other related compounds on the activity of the aminopeptidases involved in the metabolism of Ang II and AngIII. We conclude that these enzyme activities may be modified in different way, and therefore, possible modifications in RAS and in cardiovascular illness may be possible too.
Keywords: Renin-angiotensin system, hypertension, aminopeptidase A, aminopeptidase B, aminopeptidase N, fatty acids, cholesterol, dietary manipulation
Cardiovascular & Hematological Agents in Medicinal Chemistry
Title: Dietary Fat and Hypertension: A Novel Approach Through the Proteolytic Regulatory Enzymes of the Renin-Angiotensin-System
Volume: 4 Issue: 3
Author(s): J. M. Martinez-Martos and M. J. Ramirez-Exposito
Affiliation:
Keywords: Renin-angiotensin system, hypertension, aminopeptidase A, aminopeptidase B, aminopeptidase N, fatty acids, cholesterol, dietary manipulation
Abstract: The role of individual fatty acids in blood pressure regulation is unclear, although it is known that the modifications in the levels of fatty acids in the diet are able to change the entire profile of fatty acids as well as cholesterol levels in cellular membranes. These chemical changes are accompanied by changes in the physiological state of the cellular membranes and have suggested an influence on cellular metabolism and of course, on the regulatory processes. Local and circulating renin-angiotensin-systems (RAS) are examples of systems that may be involved in the pathogenesis of hypertension. Angiotensin II (AngII) has been considered as the main effector peptide of the RAS, but other peptides derived from the metabolism of AngII, as angiotensin III (AngIII) and angiotensin IV (AngIV) have shown to play significant roles. This review will briefly summarize what is known about the effects of fatty acids, cholesterol and other related compounds on the activity of the aminopeptidases involved in the metabolism of Ang II and AngIII. We conclude that these enzyme activities may be modified in different way, and therefore, possible modifications in RAS and in cardiovascular illness may be possible too.
Export Options
About this article
Cite this article as:
Martinez-Martos M. J. and Ramirez-Exposito J. M., Dietary Fat and Hypertension: A Novel Approach Through the Proteolytic Regulatory Enzymes of the Renin-Angiotensin-System, Cardiovascular & Hematological Agents in Medicinal Chemistry 2006; 4 (3) . https://dx.doi.org/10.2174/187152506777698308
DOI https://dx.doi.org/10.2174/187152506777698308 |
Print ISSN 1871-5257 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6182 |
Call for Papers in Thematic Issues
Medicinal Plants with Beneficial Properties on Diabetes and Hypertension
Diabetes and hypertension are real scourges of the 21st century. It is imperative to act in order to find innovative solutions to this problem. Taking medications such as hypoglycemic and antihypertensive drugs may aggravate certain underlying comorbidities, such as chronic kidney disease and cardiovascular disease. This significant drawback therefore requires ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial (Thematic Issue: The Changing Face of Metabolic Syndrome and its Components in the Light of Current Knowledge)
Current Vascular Pharmacology Patents in Diagnosis of Preeclampsia
Recent Patents on Biomarkers A Review of Dietary Influences on Cardiovascular Health: Part 1: the role of Dietary Nutrients
Cardiovascular & Hematological Disorders-Drug Targets Cyclophilins in Atherosclerosis: A New Therapeutic Target?
Current Pharmaceutical Design Modulation of Vascular Function by Perivascular Adipose Tissue: Sex Differences
Current Pharmaceutical Design Perspectives in Medicinal Chemistry: Metalloprotein Inhibitors: What Have We Made and What is the Next Step?
Current Topics in Medicinal Chemistry Metabolism of Moexipril to Moexiprilat: Determination of In Vitro Metabolism Using HPLC-ES-MS
Medicinal Chemistry Neutralization of Interleukin-1β Reduces Vasospasm and Alters Cerebral Blood Vessel Density Following Experimental Subarachnoid Hemorrhage in Rats
Current Neurovascular Research Management of Obesity
Current Respiratory Medicine Reviews Function and Pharmacology of Spinally-Projecting Sympathetic Pre-Autonomic Neurones in the Paraventricular Nucleus of the Hypothalamus
Current Neuropharmacology Identification of Novel Anti-inflammatory Agents from Ayurvedic Medicine for Prevention of Chronic Diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach
Current Drug Targets Hormones and the Autonomic Nervous System are Involved in Suprachiasmatic Nucleus Modulation of Glucose Homeostasis
Current Diabetes Reviews Subject Index To Volume 6
Current Gene Therapy Formulation Development and Characterization of Controlled Release Core-in-cup Matrix Tablets of Venlafaxine HCl
Current Drug Therapy Effects of Cyclosporine A and Itraconazole on Permeability, Biliary Excretion and Pharmacokinetics of Amlidipine
Drug Metabolism Letters Cholesterol Lowering Therapy: Treat to Target or Reduce the Global Risk? The Unresolved Problem of Residual Risk
Current Pharmaceutical Design Prevention and Treatment of Alzheimer Disease and Aging: Antioxidants
Mini-Reviews in Medicinal Chemistry Hot Melt Extruded and Injection Moulded Dosage Forms: Recent Research and Patents
Recent Patents on Drug Delivery & Formulation Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Modulation of Neutrophil Function by Hormones
Current Immunology Reviews (Discontinued)